CHARACTERIZATION, TOXICITY AND THERAPEUTIC EFFICACY OF ADRIAMYCIN ENCAPSULATED IN LIPOSOMES

被引：162

作者：

OLSON, F

MAYHEW, E

MASLOW, D

RUSTUM, Y

SZOKA, F

机构：

[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL PATHOL,BUFFALO,NY 14263

[2] UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143

[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GRACE CANC DRUG CTR,BUFFALO,NY 14263

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1982年 / 18卷 / 02期

关键词：

D O I：

10.1016/0277-5379(82)90060-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：167 / &

共 22 条

[1] ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].

BLUM, RH ;

CARTER, SK .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259

[2] REGULATION OF SPONTANEOUS ACTIVITY AND GROWTH OF EMBRYONIC CHICK HEART CELLS IN TISSUE CULTURE [J].

DEHAAN, RL .

DEVELOPMENTAL BIOLOGY, 1967, 16 (03) :216-+

[3]

DOROSHOW JH, 1979, CANCER TREAT REP, V63, P855

[4] INVITRO AND INVIVO STUDIES WITH ADRIAMYCIN LIPOSOMES [J].

FORSSEN, EA ;

TOKES, ZA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 91 (04) :1295-1301

[5] DIFFERENTIAL INTERACTION OF DAUNOMYCIN, ADRIAMYCIN AND THEIR DERIVATIVES WITH HUMAN ERYTHROCYTES AND PHOSPHOLIPID BILAYERS [J].

GOLDMAN, R ;

FACCHINETTI, T ;

BACH, D ;

RAZ, A ;

SHINITZKY, M .

BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 512 (02) :254-269

[6]

GOTTLIEB JA, 1973, P AM ASSOC CANC RES, V14, P88

[7]

HULHOVEN R, 1979, CANCER CHEMOTH PHARM, V3, P243

[8] PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED ANTI-TUMOR DRUGS - STUDIES WITH VINBLASTINE, ACTINOMYCIN-D, CYTOSINE-ARABINOSIDE, AND DAUNOMYCIN [J].

JULIANO, RL ;

STAMP, D .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :21-27

[9] PROPERTIES AND BIOLOGICAL EFFECTS OF LIPOSOMES AND THEIR USES IN PHARMACOLOGY AND TOXICOLOGY [J].

KIMELBERG, HK ;

MAYHEW, EG .

CRC CRITICAL REVIEWS IN TOXICOLOGY, 1978, 6 (01) :25-79

[10]

KIMELBERG HK, 1976, CANCER RES, V36, P2949

← 1 2 3 →